The Spectrum of Dissociative Disorders are based on criteria that define the dissociative experience of depersonalization along the spatial dimension with patients having dissociative episodes typically describe the experience of being spatially removed from the first person experience. We present the unique case of a patient with Other Specified Dissociative Disorder who exhibits depersonalization in relation to the dimension of time, with no clear spatial depersonalization. We discuss our findings in light of research on disturbances in temporal perception in patients and the implication for future criteria for Dissociative Disorders
gender, age, and even facial expressions that is entirely separate from their original, unique persona. In some instances, an aura has been reported to supersede an alter being pulled from the unconscious to the subconscious. 7 The memories that many of the alters elicit are often entirely different from what the original persona has experienced, so much so that it cannot yet be explained by dementia or any other medical condition. 8 DID and other psychiatric disorders such as schizophrenia have some diagnostic features in common that can often make it challenging to differentiate these comparable conditions. Schizophrenia and DID may both exhibit auditory hallucinations, negative symptoms, some degree of cortical atrophy, and are both often associated with comorbid substance abuse. In current literature, however, clinicians have found some differentiating ideas and evidence that suggest a number of key differences between these disorders. Of note is the finding that the auditory hallucination manifested in up to 80% of patients with DID often manifest at an early age, are experienced as internal in origin, and rarely responds to antipsychotic medication. 8 Conversely, patients with schizophrenia experience hallucinations as environmental, third person, external, or internal in origin and this is usually associated with negative symptoms such as flat affect, catatonia, associability, and anhedonia. Schizophrenia has also shown better response profiles to antipsychotic medication compared to DID. 9 Some patients diagnosed with schizophrenia have also reported higher delusion scores than DID. It is important to note that one of the major diagnostic differences between these disorders is the presence of amnesia or significant disparities in time. Some theories have suggested that DID patients engage in an autohypnotic phenomenon, as a defense mechanism, and have endured significant childhood trauma that is hypothesized to potentiate the onset of the disorder. 8 In contrast, childhood trauma does not seem to be directly related to the onset of schizophrenia and other psychiatric conditions. There is evidence that up to 90% of patients with DID also meet the diagnostic criteria for PTSD. This comorbidity is important to note when examining brain imaging. In addition, other conditions such as borderline personality disorder, bipolar disorder, anxiety disorders, dysfunctional early childhood attachment styles, and childhood neglect have all been implicated or associated with DID in literature. 10 Risk factors for DID include but are not limited to chronic childhood trauma, young age (onset from 28-34 years old), suicidal ideation with previous attempts, monozygotic twins, promiscuity, gender dysphoria, substance abuse, comorbid psychiatric conditions, and depersonalization. 8,10 Many psychiatric disorders are associated with significant changes in brain morphology at gross and molecular levels. The aim of our study is to explore the possibility of using volumetric analysis of specific brain regions to support the diagno...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.